Table 4.
Univariate and multivariate analyses for OS.
| Variable | Hazard ratio | 95% CI | P value |
|---|---|---|---|
| Univariate analysis | |||
| Age (≥65/<65) | 0.707 | 0.406-1.229 | 0.219 |
| Sex (male/female) | 1.222 | 0.690-2.162 | 0.492 |
| NRS 2002 scale (<3/≥3) | 0.709 | 0.172-2.919 | 0.634 |
| PG-SGA category (B/C) | 0.956 | 0.346-2.643 | 0.930 |
| PNI (≥45/<45) | 0.806 | 0.443-1.469 | 0.482 |
| PLR (≥162/<162) | 1.166 | 0.659-2.065 | 0.598 |
| NLR (≥2.5/<2.5) | 0.833 | 0.491-1.411 | 0.497 |
| Overall QOL (improved or stable/ decreased) | 0.423 | 0.179-0.999 | 0.050 |
| Treatment selection (LGJ/ES) | 6.165 | 3.293-11.542 | <0.001 |
| Multivariate analysis | |||
| Age (≥65/<65) | 1.111 | 0.613-2.015 | 0.728 |
| PNI (≥45/<45) | 1.259 | 0.688-2.304 | 0.455 |
| PLR (≥162/<162) | 0.675 | 0.352-1.296 | 0.238 |
| NLR (≥2.5/<2.5) | 1.247 | 0.711-2.189 | 0.441 |
| Overall QOL (improved or stable/ decreased) | 1.018 | 0.369-2.805 | 0.973 |
| Treatment selection (LGJ/ES) | 6.362 | 3.285-12.321 | <0.001 |
OS, Overall survival; NRS 2002, Nutrition Risk Screening 2002; PG-SGA, Patient-Generated Subjective Global Assessment; PNI, Prognostic Nutritional Index; PLR, Platelet to lymphocyte ratio; NLR, Neutrophil to lymphocyte ratio; QOL, Quality of life.